Great Valley Advisor Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.37M | Buy |
40,657
+1,830
| +5% | +$197K | 0.1% | 192 |
|
|
2025
Q1 | $3.92M | Sell |
38,827
-1,336
| -3% | -$135K | 0.08% | 207 |
|
|
2024
Q4 | $3.59M | Sell |
40,163
-292
| -0.7% | -$26.1K | 0.08% | 229 |
|
|
2024
Q3 | $3.39M | Buy |
40,455
+1,074
| +3% | +$90K | 0.08% | 234 |
|
|
2024
Q2 | $3.03M | Buy |
39,381
+3,577
| +10% | +$275K | 0.08% | 229 |
|
|
2024
Q1 | $2.45M | Sell |
35,804
-130
| -0.4% | -$8.9K | 0.07% | 241 |
|
|
2023
Q4 | $2.08M | Buy |
35,934
+9,859
| +38% | +$570K | 0.07% | 235 |
|
|
2023
Q3 | $1.38M | Buy |
26,075
+1,371
| +6% | +$72.4K | 0.06% | 271 |
|
|
2023
Q2 | $1.34M | Buy |
24,704
+3,157
| +15% | +$171K | 0.06% | 272 |
|
|
2023
Q1 | $1.08M | Buy |
21,547
+8,580
| +66% | +$429K | 0.05% | 293 |
|
|
2022
Q4 | $600K | Sell |
12,967
-149
| -1% | -$6.9K | 0.03% | 408 |
|
|
2022
Q3 | $508K | Buy |
13,116
+474
| +4% | +$18.4K | 0.03% | 416 |
|
|
2022
Q2 | $471K | Buy |
12,642
+4,457
| +54% | +$166K | 0.03% | 437 |
|
|
2022
Q1 | $362K | Buy |
8,185
+2,896
| +55% | +$128K | 0.02% | 459 |
|
|
2021
Q4 | $225K | Buy |
5,289
+358
| +7% | +$15.2K | 0.01% | 551 |
|
|
2021
Q3 | $214K | Buy |
+4,931
| New | +$214K | 0.01% | 539 |
|